CALR expression over time was analyzed in ALK-positive lymphoma K299 cell line, showing that, even in this case, surface levels of CALR were reduced after long exposure to low-dose crizotinib (i.e., 120 nM), when compared to the untreated condition (Figure 1D). The gene discussed is CALR; the disease is lymphoma.